Ezz Life Science Holdings Ltd has released a press release.
FY21 Financial Results Commentary
Filed with ASX ·
6ix hasn’t read this filing yet.
EZZ Life Science Holdings Ltd. on 6ix
Earlier from EZZ Life Science
- Appendix 4E and Preliminary Final Report
- EZZ Q4 FY21 Investor Briefing
- EZZ secures long-term EAORON contract pricing
- Appendix 4C - quarterly
Later from EZZ Life Science
- Resignation of CEO and Executive Director
- Trading Halt
- Correction to information presented by former CEO
- Supplementary Announcement to Appendix 3Y
- Application for quotation of securities - EZZ
Follow EZZ Life Science into a list and get an email when it puts out news.
Follow EZZ Life Science